The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival analysis by tumor response of nivolumab treatment in previously treated advanced gastric cancer from the DELIVER trial (JACCRO GC-08).
 
Yu Sunakawa
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Guardant Health; Incyte; Lilly Japan; Merck; MSD K.K; Ono Pharmaceutical; Sysmex; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb Japan; Daiichi Sankyo; Merck; MSD K.K
Research Funding - Chugai Pharma; Lilly Japan; Otsuka; Sanofi; Taiho Pharmaceutical; Takeda
 
Yasuhiro Sakamoto
Honoraria - Chugai Pharma; Daiichi Sankyo Pharmaceutical; Lilly Japan; MSD K.K; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Ryohei Kawabata
No Relationships to Disclose
 
Atsushi Ishiguro
No Relationships to Disclose
 
Yusuke Akamaru
No Relationships to Disclose
 
Yosuke Kito
Honoraria - Daiichi Sakyo; Ono Pharmaceutical; Taiho Pharmaceutical
 
Masazumi Takahashi
No Relationships to Disclose
 
Jin Matsuyama
No Relationships to Disclose
 
Hiroshi Yabusaki
No Relationships to Disclose
 
Akitaka Makiyama
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Lilly Japan
 
Takahisa Suzuki
No Relationships to Disclose
 
Masahiro Tsuda
No Relationships to Disclose
 
Hisateru Yasui
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); MSD (Inst); Ono Pharmaceutical (Inst)
 
Jun Hihara
No Relationships to Disclose
 
Atsushi Takeno
No Relationships to Disclose
 
Eisuke Inoue
Consulting or Advisory Role - Nippon Tect Systems; Pfizer
Speakers' Bureau - Bristol-Myers Squibb Japan; Eisai
 
Wataru Ichikawa
Honoraria - AstraZeneca; Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Kyowa Kirin; Merck Serono; Nihonkayaku; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst)
 
Masashi Fujii
Travel, Accommodations, Expenses - Japan Clinical Cancer Research Organization